Dr Reddys Laboratories (RDY) Non Operating Income (2012 - 2026)

Dr Reddys Laboratories' Non Operating Income history runs 15 years deep, the most recent figure standing at $49.9 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 758.9% year-over-year to $49.9 million; the TTM figure through Mar 2026 stood at $50.1 million (up 834.72% YoY), while the FY2026 annual figure was $44.0 million, down 20.0% from the prior year.
• Non Operating Income was $49.9 million for Q1 2026 at Dr Reddys Laboratories, up from -$10.6 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $61.6 million in Q1 2024 to a low of -$29.0 million in Q1 2022.
• Historically, Non Operating Income has averaged $3.8 million across 5 years, with a median of -$2.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income surged 740940334.76% in 2023, then slumped 4375.22% in 2025.
• A 5-year view of Non Operating Income shows it stood at -$10.0 million in 2022, then surged by 52.68% to -$4.7 million in 2023, then jumped by 94.99% to -$236873.8 in 2024, then plunged by 4375.22% to -$10.6 million in 2025, then jumped by 570.87% to $49.9 million in 2026.
• The last three Non Operating Income figures came in at $49.9 million (Q1 2026), -$10.6 million (Q4 2025), and $18.3 million (Q2 2025), per Business Quant data.